학술논문
Final analysis of a post-marketing surveillance study of dabrafenib and trametinib combination therapy in Japanese patients with unresectable malignant melanoma with BRAF V600 mutation
Document Type
Article
Author
Source
In: Journal of Dermatology . (Journal of Dermatology, June 2023, 50(6):727-738)
Subject
Language
English
ISSN
13468138
03852407
03852407